Director/PDMR Shareholding

RNS Number : 7483P

Dechra Pharmaceuticals PLC

04 September 2017

 

4 September 2017

Dechra^® Pharmaceuticals PLC

(Dechra or the Company) 

In accordance with article 19(1) of the Market Abuse Regulations, the Company announces that on 4 September 2017 Richard Cotton purchased 8,481 ordinary shares in the Company at £19.7463 per share.

Following this transaction, Richard Cotton beneficial interest in the Company is 21,318 shares, which represents 0.023% of the current issued share capital.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Richard Cotton
2.	Reason for the notification
a)	Position/status	Director
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	N/A
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Purchase of 8,481 ordinary shares
c)	Price(s) and volumes(s)	Price(s) £19.7463	Volume(s) 8,481
d)	Aggregated information -   Aggregate volume -   Price -   Total	8,481 £19.7463 £167,468.37
e)	Date of the transaction	2017.09.04
f)	Place of the transaction	London Stock Exchange

For further information, please contact:

Melanie Hall, Company Secretary             

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHOKQDPDBKDNCK